Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-11

Clinical Trial Update: Combined Ketamine and eCBT Intervention for PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring a combined ketamine and eCBT intervention for post-traumatic stress disorder is in early stages with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Queen's University | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: UNKNOWN